We reasoned that if 7G5 binds to MR1*04 in a ligand-agnostic fashion, then saturating the surface MR1 of cancer lines expressing MR1*04 with the bacterial ligand acetyl-6-formylpterin (Ac-6-FP) should not block recognition. Here, MR1 is linked to cancer.